Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Here's Why AC Immune Stock Is Surging Today


Shares of AC Immune (NASDAQ: ACIU), a clinical-stage biopharmaceutical company, are exploding higher in response to clinical trial results. Investors excited about the company's Alzheimer's disease candidate drove the stock 50.1% higher as of 10:35 a.m. EDT on Tuesday.

AC Immune doesn't have any drugs to sell at the moment, so anything that affects the outlook for its lead candidate, semorinemab, will result in dramatic price swings. This biotech stock is shooting through the roof today thanks to phase 2 clinical trial data that was positive, but not entirely.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
Share

Comments